| Drug Name (select from list of drugs shown) |
|
|
| Patient Information |
| Patient Name: |
|
|
| Patient ID: |
|
|
| Patient Group No.: |
|
|
| Patient DOB: |
|
|
| Prescribing Physician |
| Physician Name: |
|
|
| Physician Phone: |
|
|
| Physician Fax: |
|
|
| Physician Address: |
|
|
| City, State, Zip: |
|
|
| Please circle the appropriate answer for each question. |
| 1. |
Does the patient have a relapsing form of multiple sclerosis? |
|
|
| |
[For example: relapsing-remitting MS, progressive-relapsing MS, or secondary progressive MS WITH relapses]
|
|
| |
[If no, no further questions.] |
|
| 2. |
Prior to initiating Gilenya therapy, has the patient had an inadequate response to a trial of an interferon beta agent (Avonex, Betaseron, Extavia, or Rebif) or glatiramer (Copaxone)?
|
|
|
| |
[If yes, no further questions.] |
|
| 3. |
Did the patient have a contraindication to, or intolerance of, an interferon beta agent or Copaxone? |
|
|
I affirm that the information given on this form is true and accurate as of this date.
|